Work

CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models

Year: 2013

Type: article

Source: Biochemical and Biophysical Research Communications

DOI: 10.1016/j.bbrc.2013.07.030

Authors: Tomonori Tsukahara, Ken Ohmine, Chihiro Yamamoto, Ryosuke Uchibori, Hiroyuki Ido, Takeshi Teruya, Masashi Urabe, Hiroaki Mizukami, Akihiro Kume, Masataka Nakamura, Junichi Mineno, Kazutoh Takesako, Isabelle Riviere, Michel Sadelain, Renier Brentjens, Keiya Ozawa

Institutions: Jichi Medical University, Tokyo Medical and Dental University, Takara (Japan), Takara BIO Inc. (Japan), Memorial Sloan Kettering Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Jichi Medical University, Japan Society for the Promotion of Science, National Cancer Institute

Awards: Development of immunogene therapy using T-cells expressing a chimeric antigen receptor for adult T-cell leukemia, Development of gene therapy for refractory non-Hodgkin lymphoma using T-cells expressing a chimeric antigen receptor, Development of switch promoters driven by activation signals from the chimeric antigen receptors., Genome instability caused by EVI1 oncogene activation, Cancer Center Support Grant

OpenAlex ID: W2035112571

FWCI: 0.331

Cites: 29

Cited by: 21

Related to: 10